Speakers: Pratap Singh (Pfizer), Gary Starling (Merck), Jennifer Brogdon (Novartis), Derin Keskin (Dana Farber), Paul Rennert (SugarCone Biotech), Cheni Kwok (Linear Dreams LLC), Robert Tighe (EMD Serono)
Organizers: Jing-Tao Wu, Ph.D. (Takeda Pharmaceuticals) and Pratap Singh, Ph.D. (Pfizer, Inc.)
Date: Monday, December 07, 2015
Time: 8:30-16:30
Registration fee (US$): (USD$)Regular: $225; For Academic / Unemployed: $125;
Location: Marriott Cambridge, 2 Cambridge Center, Cambridge, MA 02142
Major Sponsor: (1)Charles River;(Major Sponsorship – Afternoon Session still open)
Vendor show vendors registered to date: (9)Accutest Global; Alliance Pharma; BioreclamationIVT; Eurofins Pharma Discovery Services; InSphero Inc.; MicroConstants; Perkin Elmer; Promega; QPS LLC
Registration: https://www.PBSS.org
Registration deadline:12/6/2015  (it will close sooner if the seating cap is reached)

About the Topic

The last few years have seen transformative developments in cancer treatment through immunotherapy. This workshop aims to provide a comprehensive overview of the exciting field of cancer immunotherapy from the latest biologic insights to the immuno-oncology pathways, key learnings in translating research findings to the clinic, latest clinical data on approved immuno-oncology agents and emerging agents in the pipeline as well as trends in business partnerships.

Agenda:

8:45 Introducing meeting agenda and the field of immuno-oncology (Pratap Singh, Pfizer)

9:00 Immune checkpoint inhibitors and their roles in immuno cancer therapy (Gary Starling, Merck)

9:55 CAR T-cell therapies in immuno-oncology (Jennifer Brogdon, Novartis)

10:50 Break

11:10 Major sponsor presentation (Charles River)

11:20 Cancer vaccines: current status and future directions (Derin Keskin, Dana Farber Cancer Institute)

12:15 Lunch

1:15 Combination therapies in immune-oncology (Paul Rennert, SugarCone Biotech)

2:10 Chasing Gold: Cancer Immunotherapy Deals and Business Outlook (Cheni Kwok, Linear Dreams LLC)

2:55 Break

3:15 Preclinical models for immune-oncology (Robert Tighe, EMD Serono)

4:10 Closing remarks and vendor raffle